Recent Security Class Actions

Verve Therapeutics Inc. Common Stock (NASDAQ: VERV)

6 Days left to seek lead plaintiff status.

Company Name:Verve Therapeutics Inc. Common Stock
Stock Symbol:NASDAQ: VERV
Class Period Start:08/09/2022
Class Period End (inclusive):04/01/2024
Filing Deadline:10/28/2024

The Complaint alleges that Defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose the following adverse facts pertaining to the Company’s business, operations and prospects, which were known to Defendants or recklessly disregarded by them. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (1) Defendants did not fully disclose the circumstances under which the Heart-1 trial would be halted; (2) Defendants overstated the potential benefits of its proprietary LNP delivery system (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Verve Therapeutics Inc. Common Stock (NASDAQ: VERV) Claim Form

Name(Required)
Address
This field is for validation purposes and should be left unchanged.